1. Nat Commun. 2022 Aug 11;13(1):4528. doi: 10.1038/s41467-022-31842-y.

PTEN inhibits AMPK to control collective migration.

Peglion F(#)(1), Capuana L(#)(1)(2), Perfettini I(1), Boucontet L(3), 
Braithwaite B(1), Colucci-Guyon E(3), Quissac E(4), Forsberg-Nilsson K(5), 
Llense F(1)(6), Etienne-Manneville S(7).

Author information:
(1)Cell Polarity, Migration and Cancer Unit, Institut Pasteur, CNRS UMR3691, 
Université Paris Cité, Équipe Labellisée Ligue Contre le Cancer, F-75015, Paris, 
France.
(2)Collège doctoral, Sorbonne Université, F-75005, Paris, France.
(3)Macrophages and Development of Immunity Unit, Institut Pasteur, CNRS UMR3738, 
Paris, France.
(4)Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC University Paris 04 
UMR S1127, Institut du Cerveau, ICM, Paris, France.
(5)Department of Immunology, Genetics and Pathology and Science for Life 
Laboratory, Uppsala University, Uppsala, Sweden.
(6)Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR7622, 9 
Quai St-Bernard, 75005, Paris, France.
(7)Cell Polarity, Migration and Cancer Unit, Institut Pasteur, CNRS UMR3691, 
Université Paris Cité, Équipe Labellisée Ligue Contre le Cancer, F-75015, Paris, 
France. sandrine.etienne-manneville@pasteur.fr.
(#)Contributed equally

Pten is one of the most frequently mutated tumour suppressor gene in cancer. 
PTEN is generally altered in invasive cancers such as glioblastomas, but its 
function in collective cell migration and invasion is not fully characterised. 
Herein, we report that the loss of PTEN increases cell speed during collective 
migration of non-tumourous cells both in vitro and in vivo. We further show that 
loss of PTEN promotes LKB1-dependent phosphorylation and activation of the major 
metabolic regulator AMPK. In turn AMPK increases VASP phosphorylation, reduces 
VASP localisation at cell-cell junctions and decreases the interjunctional 
transverse actin arcs at the leading front, provoking a weakening of cell-cell 
contacts and increasing migration speed. Targeting AMPK activity not only slows 
down PTEN-depleted cells, it also limits PTEN-null glioblastoma cell invasion, 
opening new opportunities to treat glioblastoma lethal invasiveness.

© 2022. The Author(s).

DOI: 10.1038/s41467-022-31842-y
PMCID: PMC9372137
PMID: 35953476 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no competing interests.